Teleflex Incorporated (NYSE:TFX) Shares Acquired by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Teleflex Incorporated (NYSE:TFX) by 2.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,991 shares of the medical technology company’s stock after acquiring an additional 118 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Teleflex were worth $888,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in TFX. Janus Henderson Group PLC grew its holdings in shares of Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after buying an additional 147,147 shares in the last quarter. State Street Corp boosted its position in Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after acquiring an additional 21,291 shares during the last quarter. Geode Capital Management LLC grew its stake in Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock valued at $278,676,000 after acquiring an additional 5,746 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Teleflex by 0.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock valued at $105,749,000 after acquiring an additional 1,884 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its stake in Teleflex by 31.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after purchasing an additional 96,958 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Trading Down 0.1 %

NYSE TFX opened at $171.37 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market capitalization of $7.96 billion, a P/E ratio of 34.07, a PEG ratio of 1.72 and a beta of 1.16. The firm’s 50-day moving average is $179.58 and its two-hundred day moving average is $210.72. Teleflex Incorporated has a 12 month low of $169.99 and a 12 month high of $256.85.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on TFX shares. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Mizuho cut their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Truist Financial cut their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Finally, Royal Bank of Canada decreased their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, Teleflex has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.